B2M and neoplasm: We found the blood markers associated with lymphoma tumor burden including lactate dehydrogenase (LDH) and beta 2 microglobulin (β2M) were also informative with 38.6% positivity for LDH and 30.8% for β2M based on the clinical cut-offs in the current study.